Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The N-terminal domain of p53 is natively unfolded.
Dawson R, Müller L, Dehner A, Klein C, Kessler H, Buchner J. Dawson R, et al. J Mol Biol. 2003 Oct 3;332(5):1131-41. doi: 10.1016/j.jmb.2003.08.008. J Mol Biol. 2003. PMID: 14499615
Tumor specific delivery and radiation-enhanced tumor penetration of mesoporous silica nanoparticles for effective radionuclide therapy of ovarian peritoneal metastasis.
Hargrove D, Ranjbar S, Darji M, Nam S, Dawson RJ, Katugampola S, Lin X, Brown A, Carrasco-Rojas N, Goodwin C, Howell RW, Bolch WE, Jay M, Salner A, Lu X. Hargrove D, et al. Among authors: dawson rj. Int J Pharm. 2024 Dec 9;669:125071. doi: 10.1016/j.ijpharm.2024.125071. Online ahead of print. Int J Pharm. 2024. PMID: 39662854
Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin.
Thomas HMM, Mullane M, Enkel SL, McRae T, Amgarth-Duff I, Carapetis JR, Coffin J, Christophers R, Famlonga R, Jacky J, Jones M, Marsh J, McIntosh K, O'Donnell V, Pan E, Pearson G, Sibosado S, Smith B, Snelling T, Steer A, Tong SYC, Walker R, Whelan A, White K, Wright E, Bowen AC; SToP (See, Treat, Prevent skin sores and scabies) Trial. Thomas HMM, et al. EClinicalMedicine. 2024 Oct 9;77:102793. doi: 10.1016/j.eclinm.2024.102793. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39649132 Free PMC article.
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial.
Dawson R, Diacon AH, De Jager V, Narunsky K, Moodley VM, Stinson KW, Liu Y, Zheng B, Hafkin J. Dawson R, et al. Lancet Infect Dis. 2024 Nov 26:S1473-3099(24)00601-7. doi: 10.1016/S1473-3099(24)00601-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39612928 Free article.
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang VK, Imperial MZ, Phillips PPJ, Velásquez GE, Nahid P, Vernon A, Kurbatova EV, Swindells S, Chaisson RE, Dorman SE, Johnson JL, Weiner M, Sizemore EE, Whitworth W, Carr W, Bryant KE, Burton D, Dooley KE, Engle M, Nsubuga P, Diacon AH, Nhung NV, Dawson R, Savic RM; AIDS Clinical Trial Group; Tuberculosis Trials Consortium. Chang VK, et al. Among authors: dawson r. Nat Commun. 2024 Oct 30;15(1):9400. doi: 10.1038/s41467-024-53273-7. Nat Commun. 2024. PMID: 39477924 Free PMC article. Clinical Trial.
1,198 results